← Evidence map

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2019

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.

Homer C Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

85 papers cite itlatest 60 shown

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30536810